6 min readUpdated
Dysport vs Botox for Masseter: Which Suits Jaw Slimming?
Masseter treatment is off-label for both Dysport and Botox. What the trials show on dose, timeline and side effects, and how to choose a product for jaw slimming or clenching.

If you only read one thing
Both Dysport and Botox can slim a wide jaw and ease clenching, and both are off-label for the masseter. Botox has the stronger trial data, with about 91 percent of patients improved at three months. Dysport spreads a little wider, which can suit a bulky muscle, but needs about 2.5 to 3 times the units. Slimming peaks around three months, and the choice depends on your muscle and smile.
- Masseter treatment is off-label for Dysport, Botox and Daxxify; an application for Botox Cosmetic is under FDA review.
- In a 2025 phase 2b trial, about 91 percent improved at three months with 48 or 72 units of Botox, vs 22 percent with placebo.
- Slimming builds as the muscle thins and peaked at about three months in that trial.
- A temporary smile change occurred in 2.9 percent of treated patients, more often at the higher dose.
- Dysport at KORA, masseter: $4.50 / unit. Botox: $13.50 / unit.
On this page 7 sections
Dysport vs Botox for masseter treatment is a different decision from choosing a product for forehead lines, because the jaw muscle is larger, stronger and used every time you chew. In this guide I explain what the research shows for each product in the masseter, how the doses compare, when slimming becomes visible, what the side effects are, and how to choose between them.
Off-label for both: no botulinum toxin is FDA-approved for the masseter. Jaw slimming and easing clenching, grinding or TMJ-related discomfort are off-label uses of Dysport, Botox and Daxxify. In August 2026 the FDA accepted Allergan’s application to approve Botox Cosmetic for masseter muscle prominence, but that review is still pending. Off-label use is explained before treatment.
Why the masseter is treated differently
The masseter is a thick chewing muscle at the angle of the jaw, and when it is large it makes the lower face look wide or square. Neuromodulators reduce its activity, and over the following weeks the muscle becomes thinner from less use. That is why the timeline and the doses differ from treating a line on the forehead, and why the size of your muscle and how hard you clench matter so much to the plan.
The muscle also sits close to muscles that shape your smile. Placing the toxin within the body of the masseter, away from those muscles, is the main safety point in this area, whichever product is used.
What the research shows for Botox
Botox has the larger body of controlled research for the masseter. In a phase 2b trial published in the Aesthetic Surgery Journal in 2025, Steven Liew and colleagues randomized 150 adults with marked masseter prominence at 14 US sites to 48 units of Botox, 72 units, or placebo, given as three injections per side. Allergan sponsored the study.
- Results at 3 monthsAbout 91 percent in both dose groups were rated as improved on the prominence scale, compared with 22 percent on placebo. Lower-face volume fell by about 6 cubic centimeters and width by 4.2 to 4.7 millimeters.
- How long it lastedThe effect peaked at day 90 and was still significant at day 180, when 36 to 48 percent still had at least a two-grade improvement.
- Higher dose, similar result72 units did not work meaningfully better than 48 units, and the side effects that affect function were more common at the higher dose.
What the research shows for Dysport
Dysport has been studied in the masseter as well, mostly in smaller trials. In a 2024 randomized, triple-blinded trial in Scientific Reports, 26 women in Brazil received 75 units of Dysport in each masseter. Muscle thickness measured by ultrasound fell at one month. After a single treatment, the muscle largely recovered by six months. Women who received a second dose at three months kept a thinner muscle at six months, but chewing efficiency was reduced at every follow-up in both groups, and the authors advised caution with repeat injections at short intervals for purely cosmetic reasons.
I take two lessons from that trial: Dysport works in the masseter, and spacing treatments matters for function as well as for appearance.
Dose, conversion and spread
Dysport and Botox units cannot be swapped one for one, and the masseter magnifies that difference because the doses are large. Both labels state that units cannot be converted between products. Clinically, a 2015 systematic review in Movement Disorders Clinical Practice found that a Botox-to-Dysport ratio between 1:2.5 and 1:3 gave comparable results, while higher ratios brought more side effects.
| Dysport | Botox | |
|---|---|---|
| FDA status for the masseter | Off-label | Off-label (application under FDA review since August 2026) |
| Doses used in recent trials | 75 units per side | 48 or 72 units in total, split between sides |
| Spread around each injection | Wider at usual conversion ratios | Somewhat tighter |
| Strongest evidence | Smaller randomized trials | Placebo-controlled phase 2b and phase 3 trials |
On spread, a 2025 split-face trial in Dermatology and Therapy by Bennek and colleagues measured the area affected around forehead injections and found it largest with Dysport, then Botox, at a fixed 1 to 2.5 ratio. In a big muscle like the masseter, a wider field can help cover the muscle evenly. The trade-off is the smile muscles nearby, so with either product the injections should stay low and deep in the muscle, away from the front edge.
The doses in these trials are research doses, not a quote. The number of units for you is set after your jaw is examined at rest and while clenching.
Timeline and side effects
Jaw slimming is slower than line softening: the muscle relaxes within days, but the visible narrowing builds over weeks as the muscle thins, and in the Botox phase 2b trial it peaked at about three months. At six months, many are still seeing part of the effect.
The side effects to know about are mostly functional. In the 2025 Botox trial, 2.9 percent of treated patients had a temporary change in their smile, which took 60 to 101 days to resolve, and 2.9 percent had chewing fatigue or difficulty, which resolved within about a month. Both were more common at the higher dose. The Dysport trial found reduced chewing efficiency, especially with repeat doses at three months. The Botox trial reported no serious side effects attributed to the toxin.
- Assessment. A careful assessment looks at the jaw at rest and clenched, covers grinding, headaches and dental history, and explains that the treatment is off-label.
- Treatment. Injections are placed deep in the lower, back part of the masseter on each side.
- Review. The effect is judged after the muscle has had time to respond, before deciding whether anything more is needed.
- Spacing. Repeat treatments should be planned months apart, not as frequent top-ups, to protect chewing function.
What it costs at KORA
Masseter treatment uses more units than facial lines, so the total depends on the product and the size of your muscle.
Botox
Jawline slimming$13.50 / unit
Dysport
Masseter$4.50 / unit
Daxxify
Masseter, per side$8 / unit
Prices come from our current price list. Your plan and total are confirmed at a complimentary consultation before anything begins.
Learn more about Dysport and Botox at our clinic on the Scottsdale and Paradise Valley border, or read my broader Dysport vs Botox comparison and Botox safety guide.
DysportDysport in Scottsdale at KORA Aesthetics — $4.50 per unit, injected by a national clinical trainer for Galderma, the company that makes it. It spreads more than Botox, which suits broad forehead lines and crow's feet. See how the unit conversion works, why price per unit is not price per treatment, and when Dysport is the better choice.See treatment, prices and resultsFrequently asked questions
Is Dysport or Botox better for masseter reduction?
Both work. Botox has larger placebo-controlled trials in the masseter, while Dysport spreads a little wider, which can suit a bulky muscle. The choice depends on your muscle size and smile anatomy.
Is masseter Botox FDA-approved?
Not yet. Masseter treatment is off-label for every neuromodulator. In August 2026 the FDA accepted an application for Botox Cosmetic for masseter muscle prominence, and that review is ongoing.
How many units of Dysport or Botox are used for the masseter?
Recent trials used 48 or 72 units of Botox in total, or 75 units of Dysport per side. Units are not interchangeable, and your dose is set after an exam.
How long until I see jaw slimming results?
The muscle relaxes within days, but visible slimming builds over weeks and peaked at about three months in a 2025 Botox trial.
How long does masseter Botox last?
In the 2025 trial the effect peaked at three months and was still significant at six months, though it was fading by then.
Can masseter Botox affect my smile or chewing?
It can, temporarily. In the 2025 trial, 2.9 percent of treated patients had a smile change and 2.9 percent had chewing fatigue, both more common at the higher dose.
Is Botox for TMJ the same as masseter Botox?
It is the same injection into the masseter, used for clenching or TMJ-related discomfort rather than slimming. Both uses are off-label.
Sources
- Liew S, Jones D, Dayan S, Fabi S, Rivkin A, Biesman B, et al. A controlled phase 2b trial to assess the efficacy and safety of a single intervention of onabotulinumtoxinA for treating masseter muscle prominence. Aesthetic Surgery Journal, 2025
- Allergan Aesthetics (AbbVie). FDA acceptance of supplemental BLA for BOTOX Cosmetic for masseter muscle prominence. AbbVie News, August 2026
- Scientific Reports. Exploring botulinum toxin's impact on masseter hypertrophy: a randomized, triple-blinded clinical trial. Scientific Reports, 2024
- Dashtipour K, Chen JJ, Espay AJ, Mari Z, Ondo W. OnabotulinumtoxinA and abobotulinumtoxinA dose conversion: a systematic literature review. Movement Disorders Clinical Practice, 2015
- Bennek M, Rudowitz D, Kerscher M. Diffusion characteristics of letibotulinumtoxinA, onabotulinumtoxinA and abobotulinumtoxinA: a randomized split-face clinical trial. Dermatology and Therapy, 2025
- Ipsen Biopharmaceuticals. DYSPORT (abobotulinumtoxinA) prescribing information, revised 1/2023. U.S. Food and Drug Administration, 2023




